Poorly differentiated extra-axial extraskeletal chordoma diagnosed by methylation profiling: case report and analysis of brachyury expression in SWI/SNF-deficient tumors

. 2024 Apr ; 484 (4) : 621-627. [epub] 20230818

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid37594643
Odkazy

PubMed 37594643
DOI 10.1007/s00428-023-03620-8
PII: 10.1007/s00428-023-03620-8
Knihovny.cz E-zdroje

Chordoma is a rare malignant tumor with notochordal differentiation, usually affecting the axial skeleton of young patients. We report a case of a high-grade epithelioid tumor involving the synovium and soft tissues of the knee in a 74-year-old male patient. The preliminary biopsy was inconclusive, but a diagnosis of metastatic clear-cell carcinoma of unknown origin was suggested. However, imaging studies did not reveal any primary lesions. The resection specimen consisted of nests and sheets of oval to polygonal cells with discernible cell borders, clear or lightly amphophilic cytoplasm, and round to oval nuclei with occasional well-visible eosinophilic nucleoli. Rare atypical mitoses, necrotic areas, and bizarre nuclei were noted. The biopsy and resection specimens underwent a wide molecular genetic analysis which included methylation profiling. The DKFZ sarcoma classifier assigned the methylation class chordoma (dedifferentiated) with a calibrated score of 0.96, and additionally, a loss of SMARCB1 locus was noted in the copy number variation plot. To verify these findings, T-brachyury and SMARCB1 immunostaining was performed afterward, showing diffuse nuclear positivity and complete loss in the tumor cells, respectively. To assess the prevalence of T-brachyury immunopositivity among SWI/SNF-deficient tumors and to evaluate its specificity for poorly differentiated chordoma, we analyzed a series of 23 SMARCB1- or SMARCA4-deficient tumors, all of which were negative. After incorporating all the available data, including the absence of any morphological features of conventional chordoma, the case was diagnosed as poorly differentiated chordoma. As illustrated herein, the utilization of methylation profiling in the diagnostic process of some carefully selected unclassifiable soft tissue neoplasms may lead to an increased detection rate of such extremely rare soft tissue tumors and enable their better characterization.

Zobrazit více v PubMed

Vujovic S, Henderson S, Presneau N et al (2006) Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol 209(2):157–165 PubMed DOI

Tirabosco R, Mangham DC, Rosenberg AE et al (2008) Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue. Am J Surg Pathol 32(4):572–580 PubMed DOI

Salisbury JR, Isaacson PG (1985) Demonstration of cytokeratins and an epithelial membrane antigen in chordomas and human fetal notochord. Am J Surg Pathol 9(11):791–797 PubMed DOI

Scolyer RA, Bonar SF, Palmer AA et al (2004) Parachordoma is not distinguishable from axial chordoma using immunohistochemistry. Pathol Int 54(5):364–370 PubMed DOI

WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2020 [cited 2023 May 9]. (WHO classification of tumours series, 5th ed.; vol. 3). Available from: https://tumourclassification.iarc.who.int/chapters/33

Lv GH, Zou MX, Liu FS et al (2019) Clinicopathological and prognostic characteristics in extra-axial chordomas: an integrative analysis of 86 cases and comparison with axial chordomas. Neurosurgery 85(3):E527–E542 PubMed DOI

Neumann J, Gersing AS, Barth TF, Boxberg M, Woertler K (2019) Intra-articular extra-axial chordoma of the wrist: a case report with review of the current literature. Skelet Radiol 48(12):2015–2020 DOI

Ueda T, Kubota K, Shiroma N et al (2020) Extra-axial chordoma of the gingiva. Auris Nasus Larynx 47(2):299–304 PubMed DOI

Balogh P, O'Donnell P, Lindsay D, Amary MF, Flanagan AM, Tirabosco R (2020) Extra-axial skeletal poorly differentiated chordoma: a case report. Histopathology 76(6):924–927 PubMed DOI

Ball S, Dash A, Igid HP, Thein KZ, Sharma U, Tijani L (2020) Primary extra-axial chordoma masquerading as lung cancer: case report and review of the literature. Clin Lung Cancer 21(6):e560–e563 PubMed DOI

Lee S, Halpern JL, Liang J (2021) Pediatric extra-axial chordoma: case report and literature review. Pediatr Dev Pathol 24(6):585–591 PubMed DOI

Tehrani SG, Kaltoft NS, Melchior LC, Loya AC (2021) Extra-axial chordoma of the thumb: report of a rare case with clinicopathologic and molecular analysis. Pathol Res Pract 225:153564 PubMed DOI

Kurzawa P, Fundowicz M, Dopierała M, Larque AB, Nielsen GP (2018) Primary extra-axial, para-articular chordoma of the knee. A case report and the review of literature. Histopathology 72(5):883–885 PubMed DOI

Righi A, Sbaraglia M, Gambarotti M et al (2018) Extra-axial chordoma: a clinicopathologic analysis of six cases. Virchows Arch 472(6):1015–1020 PubMed DOI

Shih AR, Cote GM, Chebib I et al (2018) Clinicopathologic characteristics of poorly differentiated chordoma. Mod Pathol 31(8):1237–1245 PubMed DOI

Koelsche C, Schrimpf D, Stichel D et al (2021) Sarcoma classification by DNA methylation profiling. Nat Commun 12:498 PubMed DOI PMC

Wen X, Cimera R, Aryeequaye R, Abhinta M, Athanasian E, Healey J, Fabbri N, Boland P, Zhang Y, Hameed M (2021) Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: a clinicopathological and molecular analysis. Genes Chromosom Cancer 60(12):796–807 PubMed DOI

Rekhi B, Michal M, Ergen FB et al (2021) Poorly differentiated chordoma showing loss of SMARCB1/INI1: clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity. Ann Diagn Pathol 55:151809 PubMed DOI

Capper D, Jones DTW, Sill M et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474 PubMed DOI PMC

Kohashi K, Yamamoto H, Yamada Y, Kinoshita I, Oda Y (2021) Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor. Hum Pathol 112:1–8 PubMed DOI

Kinoshita I, Kohashi K, Yamamoto H et al (2021) Myxoepithelioid tumour with chordoid features: a clinicopathological, immunohistochemical and genetic study of 14 cases of SMARCB1/INI1-deficient soft-tissue neoplasm. Histopathology 79(4):629–641 PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...